Method to prevent side-effects and insensitivity to the therapeutic uses of toxins
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 8, 1996
Issued Date -
N/A
app pub date -
Jun 6, 1994
filing date -
May 14, 1993
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Human-derived or human-compatible antitoxins are administered is an adjunct to therapy with a toxin, such as botulinum toxin or an immunotoxin, or as an adjunct to therapy with a combination of toxins, in order to reduce or prevent endogenous production of antibodies to the toxin(s) or other unwanted side-effects.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully